Viridian Therapeutics, Inc. (VRDN)
33.26
+0.23
(+0.70%)
USD |
NASDAQ |
Jan 16, 16:00
33.20
-0.06
(-0.18%)
After-Hours: 20:00
Viridian Therapeutics Market Cap: 3.174B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 30.18M |
| Orthofix Medical, Inc. | 556.38M |
| ADMA Biologics, Inc. | 4.120B |
| Avantor, Inc. | 8.291B |
| Immunovant, Inc. | 4.605B |
Market Cap Related Metrics
| PS Ratio | 38.15 |
| Price to Book Value | 10.11 |
| Price | 33.26 |
| Earnings Yield | -10.62% |